Sequence information
DRAVP ID DRAVPc021
Name Interferon alfacon-1
Sequence
Molecular Formula C860H1353N227O255S9
Condition/Disease Chronic HCV infection
Group Approved
Type Protein
Description Interferon alfacon-1 is a recombinant interferon similar the interferon alfa subtype which is used to treat hepatitis C infections.
Active sequence/Structure
External Links
DrugBank Accession Number DB00069
Pubchem ID 46505985
CHEMBL ID CHEMBL1201557
UNII 56588OP40D
CAS 118390-30-0
Reference 8836913
ClinicalTrails Information
| NCT Number | Study Title | Condition/Disease | Status | Phase | Sponsor |
|---|---|---|---|---|---|
| NCT00211692 | Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial | Chronic Hepatitis C Virus (HCV) Infection Treatment | Completed | Phase 3 | Minneapolis Veterans Affairs Medical Center |
| NCT00086541 | Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy | Chronic Hepatitis C Virus (HCV) Infection Treatment | Completed | Phase 3 | Bausch Health Americas, Inc. |
| NCT00266318 | Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy | Hepatitis C Virus (HCV) Infection Treatment | Completed | Phase 4 | Beth Israel Medical Center |
| NCT00207402 | Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin | Hepatitis C Virus (HCV) Infection Treatment | Completed | Phase 4 | Brooke Army Medical Center |
